Paul ChapmanBSc, PhD


Chartered (UK) and European Patent Attorney

Offices: Edinburgh (UK)

Languages spoken: English


Telephone (Office): +44 131 221 7000

Download vCard


Paul Chapman

Paul is a Chartered (UK) and European Patent Attorney with over 20 years of experience in the IP profession. A number of his clients have worked with him since he started in the profession and still do so to this day. His clients range from universities and SMEs to large multinational companies particularly in the biotechnology, chemistry and pharmaceutical fields.

He has significant expertise in biologics including, antibody technology, cell therapies, RNAi and vaccines. Paul also carries out a significant amount of work in relation to molecular diagnostics, medical devices, anaerobic digestion, drug delivery, cancer therapeutics, catalysis, nanotechnology and DNA technologies. He has experience of European Opposition and Appeal procedures, in particular, in the areas of biotechnology, molecular biology and chemistry. Paul also has considerable experience of filing and prosecuting SPC applications throughout Europe. As well as prosecution and opposition work, Paul provides strategic advice to ensure that his clients get the best out of their IP.

Paul is Managing Partner of the firm's Edinburgh office and also chair of Marks & Clerk's Life Sciences committee, having authored and/or edited a number of the firm's life sciences reports and other publications. Paul is a regular speaker at bioscience conferences and has given many presentations and workshops to universities and other clients.

Paul was recommended in 2016 by IAM Patent 1000, which says that “he constantly provides excellent service”. He was recommended in the 2015 edition of Legal 500, and mentioned in 2016. For the last two consecutive years he has also been listed as ‘IP Star’ by Managing Intellectual Property.

Paul was brought up and educated in Edinburgh. He obtained an honours degree in microbiology from the University of Glasgow, followed by a doctorate in molecular biology.

Paul Chapman works in the following sectors

Medical devices

Beyond pharma: The role of medtech in antimicrobial resistance

POSTED 14 December 2018
Longitude Report 2018

Longitude Report 2018

POSTED 15 October 2018

You may also be interested in...

The Unitary Patent and Unified Patent Court

The Unitary Patent and Unified Patent Court

One of the most significant changes to the European patent system since the creation of the European Patent Organisation

Our news

Marks & Clerk hosts the inaugural Cambridge IP Summit

POSTED 31 October 2018

Provisions for Regulating Trademark Application Actions

POSTED 18 February 2019

Find the right person

Find the office that suits you

Click here to view our offices